ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RSMDF is expected to report earnings to 27 cents per share on April 23
Q1'26
Est.
$0.28
Q4'25
Beat
by $0.01
Q3'25
Est.
$0.25
Q2'25
Beat
by $0.01
Q1'25
Est.
$0.24
The last earnings report on January 29 showed earnings per share of 28 cents, beating the estimate of 27 cents. With 124.00 shares outstanding, the current market capitalization sits at 36.63B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RSMDF showed earnings on January 29, 2026. You can read more about the earnings report here.